Korean Journal of Medical History10.13081/kjmh.2021.30.2772021302277-315Changes in pharmaceutical market and “fake drug” problem in the Qing periodJihee CHOI,,
Drug Information Journal10.1177/009286159803200110199832173-77Development of ADR Monitoring Activities in Poland Subsequent to Changes in the Pharmaceutical MarketAndrzej Czarnecki,,,
Pharmaceutical Anti‐Counterfeiting10.1002/9781118023679.oth32011385-389Drug Regulators,
Pharmaceutical Anti‐Counterfeiting10.1002/9781118023679.ch3201115-19A Snapshot of the Problem,
Saudi Pharmaceutical Journal10.1016/j.jsps.2018.02.0202018265703-708Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year periodO. Ferrández, S. Grau, O. Urbina, S. Mojal, M. Riu, E. Salas,
Drug Testing and Analysis10.1002/dta.31192021What's in fake ‘Xanax’?: A dosage survey of designer benzodiazepines in counterfeit pharmaceutical tabletsKaren Blakey, Amanda Thompson, Abbey Matheson, Andrew Griffiths,,
Reviews on Clinical Pharmacology and Drug Therapy10.17816/rcf183245-2542020183245-254Structural changes in the Russian pharmaceutical market of anti-tb drugsNatalia E. Usacheva, Vasiliy E. Novikov, Tatyana V. Myakisheva, Nadezhda A. Pavluchenkova, Elena V. Trun,
Nature Reviews Drug Discovery10.1038/nrd46972015149594-595Forecasting market share in the US pharmaceutical marketStephane A. Regnier, David B. Ridley,,
10.1007/978-3-319-15576-02015Approaching China's Pharmaceutical Market,
Journal of Pharmaceutical Sciences10.1002/jps.2600711102198271111191Solving the Orphan Drug ProblemEdward G. Feldmann,